These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 31165977)

  • 41. Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.
    Michaud JE; Kim KS; Harty W; Kasprenski M; Wang MH
    BMC Microbiol; 2017 May; 17(1):127. PubMed ID: 28545489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia.
    Dadi BR; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
    BMC Infect Dis; 2020 Feb; 20(1):108. PubMed ID: 32033541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.
    Derakhshandeh S; Shahrokhi N; Khalaj V; Habibi M; Moazzezy N; Asadi Karam MR; Bouzari S
    Microb Pathog; 2020 Apr; 141():103974. PubMed ID: 31926238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic
    Salamzade R; McElheny CL; Manson AL; Earl AM; Shaikh N; Doi Y
    mSphere; 2023 Oct; 8(5):e0018423. PubMed ID: 37581436
    [No Abstract]   [Full Text] [Related]  

  • 45. The DraC usher in Dr fimbriae biogenesis of uropathogenic E. coli Dr(+) strains.
    Zalewska-Piatek B; Kur M; Wilkanowicz S; Piatek R; Kur J
    Arch Microbiol; 2010 May; 192(5):351-63. PubMed ID: 20349311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
    Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
    Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FNR regulates expression of important virulence factors contributing to pathogenicity of uropathogenic Escherichia coli.
    Barbieri NL; Nicholson B; Hussein A; Cai W; Wannemuehler YM; Dell'Anna G; Logue CM; Horn F; Nolan LK; Li G
    Infect Immun; 2014 Dec; 82(12):5086-98. PubMed ID: 25245807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of virulence factors and phylogenetic characterization of uropathogenic Escherichia coli causing urinary tract infection in patients with and without diabetes mellitus.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    Trans R Soc Trop Med Hyg; 2015 Dec; 109(12):769-74. PubMed ID: 26567223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive Identification of Fim-Mediated Inversions in Uropathogenic Escherichia coli with Structural Variation Detection Using Relative Entropy.
    Russell CW; Sukumaran R; Liow LT; Periaswamy B; Rafee S; Chee YC; Chen SL
    mSphere; 2019 Apr; 4(2):. PubMed ID: 30971446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Gene Expression Profile of Uropathogenic Escherichia coli in Women with Uncomplicated Urinary Tract Infections Is Recapitulated in the Mouse Model.
    Frick-Cheng AE; Sintsova A; Smith SN; Krauthammer M; Eaton KA; Mobley HLT
    mBio; 2020 Aug; 11(4):. PubMed ID: 32788379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular Analysis of
    Abdul Raheem Hasan S; Sajid Al-Jubori S; Abdul Sattar Salman J
    Arch Razi Inst; 2021 Oct; 76(4):829-840. PubMed ID: 35096318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic
    Goh KGK; Phan MD; Forde BM; Chong TM; Yin WF; Chan KG; Ulett GC; Sweet MJ; Beatson SA; Schembri MA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virulence behavior of uropathogenic Escherichia coli strains in the host model Caenorhabditis elegans.
    Schifano E; Marazzato M; Ammendolia MG; Zanni E; Ricci M; Comanducci A; Goldoni P; Conte MP; Uccelletti D; Longhi C
    Microbiologyopen; 2019 Jun; 8(6):e00756. PubMed ID: 30381890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium.
    Saldaña Z; De la Cruz MA; Carrillo-Casas EM; Durán L; Zhang Y; Hernández-Castro R; Puente JL; Daaka Y; Girón JA
    PLoS One; 2014; 9(7):e101200. PubMed ID: 25036370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peptidoglycan endopeptidase MepM of uropathogenic Escherichia coli contributes to competitive fitness during urinary tract infections.
    Huang WC; Dwija IBNP; Hashimoto M; Wu JJ; Wang MC; Kao CY; Lin WH; Wang S; Teng CH
    BMC Microbiol; 2024 May; 24(1):190. PubMed ID: 38816687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Escherichia coli 83972 expressing a P fimbriae oligosaccharide receptor mimic impairs adhesion of uropathogenic E. coli.
    Watts RE; Tan CK; Ulett GC; Carey AJ; Totsika M; Idris A; Paton AW; Morona R; Paton JC; Schembri MA
    J Infect Dis; 2012 Oct; 206(8):1242-9. PubMed ID: 22872729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fast identification of Escherichia coli in urinary tract infections using a virulence gene based PCR approach in a novel thermal cycler.
    Brons JK; Vink SN; de Vos MGJ; Reuter S; Dobrindt U; van Elsas JD
    J Microbiol Methods; 2020 Feb; 169():105799. PubMed ID: 31790780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
    Yun KW; Kim HY; Park HK; Kim W; Lim IS
    J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compounds targeting YadC of uropathogenic Escherichia coli and its host receptor annexin A2 decrease bacterial colonization in bladder.
    Li X; Pei G; Zhang L; Cao Y; Wang J; Yu L; Dianjun W; Gao S; Zhang ZS; Yao Z; Wang Q
    EBioMedicine; 2019 Dec; 50():23-33. PubMed ID: 31757778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli.
    Cadieux PA; Burton J; Devillard E; Reid G
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():13-8. PubMed ID: 20224146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.